The authors performed immunohistochemical analysis of CD133 expression in 119 tumor tissue samples and matched normal liver tissue samples from patients with hepatocellular carcinoma who had not received chemotherapy or targeted therapy before surgery. The gene discussed is PROM1; the disease is hepatocellular carcinoma.